The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 685K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

28 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands fora-Synuclein Fibrils.EBI
Washington University
Synthesis and in vitro evaluation ofa-synuclein ligands.EBI
Washington University
Structure-Activity Relationships of Cyano-substituted Indole Derivatives as Ligands for α-Synuclein Aggregates.EBI
Beijing Normal University
Hybrids of polyphenolic/quinone acids, the potential preventive and therapeutic drugs for PD: Disaggregate α-Syn fibrils, inhibit inclusions, and repair damaged neurons in mice.EBI
Zhengzhou University
Discovery of Small-Molecule Degraders for Alpha-Synuclein Aggregates.EBI
Sun Yat-Sen University
Bis-chalcone polyphenols with potential preventive and therapeutic effects on PD: Design, synthesis and in vitro disaggregation activity against α-synuclein oligomers and fibrils.EBI
Zhengzhou University
4-Arylidene curcumin derivatives in vitro inhibit α-Synuclein aggregation and disaggregate the preformed fibril.EBI
Zhengzhou University
Targeted Degradation of Alpha-Synuclein by Autophagosome-Anchoring Chimera Peptides.EBI
Sun Yat-Sen University
Small molecule-based fluorescent probes for the detection of α-Synuclein aggregation states.EBI
Csir-Indian Institute of Chemical Technology (CSIR-IICT)
Evolution in non-peptide α-helix mimetics on the road to effective protein-protein interaction modulators.EBI
IQM-CSIC
Bioactive Aurones, Indanones, and Other Hemiindigoid Scaffolds: Medicinal Chemistry and Photopharmacology Perspectives.EBI
Universite Grenoble Alpes
Discovery of novel 6-hydroxybenzothiazole urea derivatives as dual Dyrk1A/α-synuclein aggregation inhibitors with neuroprotective effects.EBI
German University In Cairo
Hybrids of polyphenolic acids and xanthone, the potential preventive and therapeutic effects on PD: Design, synthesis, in vitro anti-aggregation of α-synuclein, and disaggregation against the existed α-synuclein oligomer and fibril.EBI
Zhengzhou University
Discovery of styrylaniline derivatives as novel alpha-synuclein aggregates ligands.EBI
Fudan University
Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation.EBI
University of Catania
Design, synthesis and identification of N, N-dibenzylcinnamamide (DBC) derivatives as novel ligands for α-synuclein fibrils by SPR evaluation system.EBI
Fudan University
Amide derivatives of Gallic acid: Design, synthesis and evaluation of inhibitory activities against in vitro α-synuclein aggregation.EBI
Zhengzhou University
Anti-oligomerization sheet molecules: Design, synthesis and evaluation of inhibitory activities against α-synuclein aggregation.EBI
Zhengzhou University
Novel Bis-heteroaryl Derivatives To Modulate Protein Aggregation for the Treatment of Neurodegenerative Diseases.EBI
Drexel University
A routinely used protein staining dye acts as an inhibitor of wild type and mutant alpha-synuclein aggregation and modulator of neurotoxicity.EBI
National Institute of Immunology
NOVEL DIOXANE DERIVATIVESBDB
Boehringer Ingelheim International
Indazole inhibitors of fructokinase (KHK) and methods of use in treating KHK-mediated disorders or diseasesBDB
Regents of The University of Colorado, A Body Corporate
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersBDB
Galapagos
USP30 inhibitorsBDB
Mitobridge
Imidazo isoindole derivative, preparation method therefor and medical use thereofBDB
Jiangsu Hengrui Medicine
PSMA imaging agentsBDB
Siemens Medical Solutions Usa
Dipeptidyl-quinolone derivatives inhibit hypoxia inducible factor-1a prolyl hydroxylases-1, -2, and -3 with altered selectivity.BDB
Amgen
Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity.BDB
University of Rochester